APO Research
Talk to an analyst

APO RESEARCH · REPORT

DPT Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global DPT Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025189 pages

Choose your research edition.

Industry ResearchDPT Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal DPT Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global DPT Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DPT Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DPT Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DPT Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DPT Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

DPT Vaccines Segment by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

DPT Vaccines Segment by Type

DTaP

Tdap

DTwP

DPT Vaccines Segment by Age

12 Months Below

12 Months Above

DPT Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DPT Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of DPT Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of DPT Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. DPT Vaccines Industry Trends Table 2. DPT Vaccines Industry Drivers Table 3. DPT Vaccines Industry Opportunities and Challenges Table 4. DPT Vaccines Industry Restraints Table 5. Global DPT Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global DPT Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global DPT Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global DPT Vaccines Sales Market Share by Manufacturers Table 9. Global DPT Vaccines Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global DPT Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global DPT Vaccines Manufacturers, Product Type & Application Table 13. Global DPT Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global DPT Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DTaP Table 17. Major Manufacturers of Tdap Table 18. Major Manufacturers of DTwP Table 19. Global DPT Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Global DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 22. Global DPT Vaccines Sales Market Share by Type (2021-2026) Table 23. Global DPT Vaccines Sales Market Share by Type (2027-2032) Table 24. Global DPT Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 25. Global DPT Vaccines Revenue by Type (2021-2026) & (M Doses) Table 26. Global DPT Vaccines Revenue by Type (2027-2032) & (M Doses) Table 27. Global DPT Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global DPT Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of 12 Months Below Table 30. Major Manufacturers of 12 Months Above Table 31. Global DPT Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global DPT Vaccines Sales by Application (2021-2026) & (M Doses) Table 33. Global DPT Vaccines Sales by Application (2027-2032) & (M Doses) Table 34. Global DPT Vaccines Sales Market Share by Application (2021-2026) Table 35. Global DPT Vaccines Sales Market Share by Application (2027-2032) Table 36. Global DPT Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 37. Global DPT Vaccines Revenue by Application (2021-2026) & (M Doses) Table 38. Global DPT Vaccines Revenue by Application (2027-2032) & (M Doses) Table 39. Global DPT Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global DPT Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global DPT Vaccines Sales by Region (2021-2026) & (M Doses) Table 43. Global DPT Vaccines Sales Market Share by Region (2021-2026) Table 44. Global DPT Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 45. Global DPT Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 47. North America DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 48. North America DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 49. Europe DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. Europe DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 51. Europe DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 52. Asia Pacific DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Asia Pacific DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 54. Asia Pacific DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 55. South America, Middle East and Africa DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. South America, Middle East and Africa DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. South America, Middle East and Africa DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 58. Global DPT Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global DPT Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global DPT Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global DPT Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global DPT Vaccines Revenue Market Share by Region (2027-2032) Table 63. Sanofi Pasteur Company Information Table 64. Sanofi Pasteur Business Overview Table 65. Sanofi Pasteur DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur DPT Vaccines Product Portfolio Table 67. Sanofi Pasteur Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK DPT Vaccines Product Portfolio Table 72. GSK Recent Development Table 73. Mitsubishi Tanabe Pharma Company Information Table 74. Mitsubishi Tanabe Pharma Business Overview Table 75. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio Table 77. Mitsubishi Tanabe Pharma Recent Development Table 78. KM Biologics Company Information Table 79. KM Biologics Business Overview Table 80. KM Biologics DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. KM Biologics DPT Vaccines Product Portfolio Table 82. KM Biologics Recent Development Table 83. Wuhan Institute of Biological Products Company Information Table 84. Wuhan Institute of Biological Products Business Overview Table 85. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio Table 87. Wuhan Institute of Biological Products Recent Development Table 88. Walvax Biotechnology Company Information Table 89. Walvax Biotechnology Business Overview Table 90. Walvax Biotechnology DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Walvax Biotechnology DPT Vaccines Product Portfolio Table 92. Walvax Biotechnology Recent Development Table 93. Chengdu Institute of Biological Products Company Information Table 94. Chengdu Institute of Biological Products Business Overview Table 95. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio Table 97. Chengdu Institute of Biological Products Recent Development Table 98. Minhai Biotechnology Company Information Table 99. Minhai Biotechnology Business Overview Table 100. Minhai Biotechnology DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Minhai Biotechnology DPT Vaccines Product Portfolio Table 102. Minhai Biotechnology Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. DPT Vaccines Distributors List Table 106. DPT Vaccines Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. DPT Vaccines Product Image Figure 2. Global DPT Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global DPT Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global DPT Vaccines Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DTaP Image Figure 9. Tdap Image Figure 10. DTwP Image Figure 11. Global DPT Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global DPT Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global DPT Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global DPT Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 15. Global DPT Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global DPT Vaccines Revenue Market Share by Type (2021-2032) Figure 17. 12 Months Below Image Figure 18. 12 Months Above Image Figure 19. Global DPT Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global DPT Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global DPT Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global DPT Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global DPT Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global DPT Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 26. North America DPT Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Canada DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Mexico DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe DPT Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. France DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. U.K. DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Italy DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Netherlands DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific DPT Vaccines Sales Market Share by Country (2021-2032) Figure 39. China DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Japan DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. South Korea DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Southeast Asia DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. India DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Australia DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa DPT Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South Africa DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Saudi Arabia DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Turkey DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Argentina DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. UAE DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Egypt DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Chile DPT Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Global DPT Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global DPT Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America DPT Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe DPT Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific DPT Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa DPT Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. DPT Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. DPT Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • DTaP
  • Tdap
  • DTwP
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Chengdu Institute of Biological Products
  • Minhai Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DPT Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DPT Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global DPT Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global DPT Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global DPT Vaccines Market Dynamics
  1. 2.1 DPT Vaccines Industry Trends
  2. 2.2 DPT Vaccines Industry Drivers
  3. 2.3 DPT Vaccines Industry Opportunities and Challenges
  4. 2.4 DPT Vaccines Industry Restraints
3 DPT Vaccines Market by Manufacturers
  1. 3.1 Global DPT Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global DPT Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global DPT Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global DPT Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global DPT Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global DPT Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DPT Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DPT Vaccines Tier 1, Tier 2, and Tier 3
4 DPT Vaccines Market by Type
  1. 4.1 DPT Vaccines Type Introduction
  2. 4.1.1 DTaP
  3. 4.1.2 Tdap
  4. 4.1.3 DTwP
  5. 4.2 Global DPT Vaccines Sales by Type
  6. 4.2.1 Global DPT Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global DPT Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global DPT Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global DPT Vaccines Revenue by Type
  10. 4.3.1 Global DPT Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global DPT Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global DPT Vaccines Revenue Market Share by Type (2021-2032)
5 DPT Vaccines Market by Application
  1. 5.1 DPT Vaccines Application Introduction
  2. 5.1.1 12 Months Below
  3. 5.1.2 12 Months Above
  4. 5.2 Global DPT Vaccines Sales by Application
  5. 5.2.1 Global DPT Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DPT Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global DPT Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global DPT Vaccines Revenue by Application
  9. 5.3.1 Global DPT Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DPT Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global DPT Vaccines Revenue Market Share by Application (2021-2032)
6 Global DPT Vaccines Sales by Region
  1. 6.1 Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DPT Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global DPT Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global DPT Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America DPT Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe DPT Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific DPT Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa DPT Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa DPT Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global DPT Vaccines Revenue by Region
  1. 7.1 Global DPT Vaccines Revenue by Region
  2. 7.1.1 Global DPT Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global DPT Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global DPT Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global DPT Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America DPT Vaccines Revenue (2021-2032)
  8. 7.2.2 North America DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe DPT Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific DPT Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa DPT Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa DPT Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK DPT Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Mitsubishi Tanabe Pharma
  14. 8.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 8.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 8.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
  18. 8.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 8.4 KM Biologics
  20. 8.4.1 KM Biologics Company Information
  21. 8.4.2 KM Biologics Business Overview
  22. 8.4.3 KM Biologics DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 KM Biologics DPT Vaccines Product Portfolio
  24. 8.4.5 KM Biologics Recent Developments
  25. 8.5 Wuhan Institute of Biological Products
  26. 8.5.1 Wuhan Institute of Biological Products Company Information
  27. 8.5.2 Wuhan Institute of Biological Products Business Overview
  28. 8.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
  30. 8.5.5 Wuhan Institute of Biological Products Recent Developments
  31. 8.6 Walvax Biotechnology
  32. 8.6.1 Walvax Biotechnology Company Information
  33. 8.6.2 Walvax Biotechnology Business Overview
  34. 8.6.3 Walvax Biotechnology DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
  36. 8.6.5 Walvax Biotechnology Recent Developments
  37. 8.7 Chengdu Institute of Biological Products
  38. 8.7.1 Chengdu Institute of Biological Products Company Information
  39. 8.7.2 Chengdu Institute of Biological Products Business Overview
  40. 8.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
  42. 8.7.5 Chengdu Institute of Biological Products Recent Developments
  43. 8.8 Minhai Biotechnology
  44. 8.8.1 Minhai Biotechnology Company Information
  45. 8.8.2 Minhai Biotechnology Business Overview
  46. 8.8.3 Minhai Biotechnology DPT Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
  48. 8.8.5 Minhai Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DPT Vaccines Value Chain Analysis
  2. 9.1.1 DPT Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DPT Vaccines Production Mode & Process
  6. 9.2 DPT Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DPT Vaccines Distributors
  9. 9.2.3 DPT Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst